Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Paul Wang to serve as the company's managing director in China

Wang joins O-I from International Paper (NYSE:IP), where he held a number of senior level positions in sales and marketing, business development, government relations and general management, including managing the large.

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

In his new role at O-I, Wang will be located in Shanghai and will assume responsibility for all of the company's operations in China. As part of his role, Wang will also support global operations through low cost strategic sourcing from China through O-I's China Trading Company and Tianjin Mould Company. A top priority will be accelerating O-I's growth strategy in China, including organic growth and merger and acquisition activity.

"Paul brings a unique set of capabilities to this role including proven leadership and general management skills, experience with both packaging and glass companies, deep knowledge of the Chinese business environment and expertise in business development, all of which will be of great value as O-I grows its business in," said
Greg Ridder, president of O-I Asia Pacific.
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?